This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In doing so it’s compounded pre-existing pressure with pharma, where schedules are shrinking and policies are often already restrictive enough to build barriers for effective physician engagement. The threat of disease spread and other risk factors from COVID-19 have only compounded this.
While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. This high compound annual growth rate of 23.6%
Some takeaways on those efforts that we gleaned from the report: Compounding. OC devoted a lot of resources to its compliance efforts directed at human drug compounding. Communication in this area included on-line videos, webinars, summits, conferences, and international outreach. Drug Supply Chain.
For example, process simulators can report model-based air emissions such as volatile organic compounds (VOCs) with great accuracy since they are grounded in robust physical properties calculations, like activity coefficient models, that are embedded in the simulators. These calculations are then shared with the environmental agencies.
At this stage, lead compounds will be ranked based on their activity in primary and secondary assays, demonstrating acceptable specificity and selectivity for the biological target that is proposed to be key for the desired therapeutic area. We start by using in-silico modeling of any pre-existing data associated with the lead compounds.
I nefficient workflows and lack of data visibility compound Pharmacy challenges. Learn more about Dr. Rab’s perspective on the pharmacist’s role on the care team by viewing this recent webinar on how digital transformation frees pharmacists to provide culturally competent care to all patients.
Fewer than 15% of healthcare systems currently automate sterile compounding, yet in an average outpatient pharmacy, it is estimated that four medication errors occur every single day.
Fewer than 15% of healthcare systems currently automate sterile compounding, yet in an average outpatient pharmacy, it is estimated that four medication errors occur every single day.
A recent pharmaphorum webinar on digital transformation , held in association with P360, explored how COVID has fast-tracked pharma’s long-held ambitions to make wider use of digital technology and streamline its communications with HCPs. Physician access issues coupled with message delivery disconnects only compounded the problem.
This can be through blogs, webinars, or even informal gatherings where we discuss our successes and failures. I really got to know him about 10 years ago when I did a 3-day compounding training inside his pharmacy. He was paying me to teach him and his team about compounds. A great place to learn is our BLOG.
This education can be delivered through various formats, such as webinars, videos, and written materials. This challenge is further compounded by varying levels of health literacy among patients, requiring pharma companies to communicate complex medical information in ways that are understandable to a broad audience.
Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. How does bioavailability play a role in biopharmaceutics? Now fraction absorbed and bioavailability are often confused and used interchangeably.
When it comes to highly sensitive large-molecule drugs, sourcing premium elastomeric components with a cleaner compound, such as Datwyler’s FM457, is an essential step in reducing the E&L risk. This on-demand webinar discusses the importance of a patient-appropriate BL & GF profile.
From alcohols to quaternary ammonium compounds, each type of agent has a unique mode of action, with varying degrees of efficacy. Later in the webinar, she also shares the results of a recent study investigating the efficacy of BKC against gram positive and gram negative bacteria and yeast. Is Benzalkonium Chloride a good choice?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content